Surfactant treatment regimen

Details Surfactant treatment regimen Surfactant treatment regimen

2006-01-06

2009-06-02

Ramirez, Delia M (Department: 1656)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S012200, C514S013800, C514S579000

Reexamination Certificate

active

07541331

ABSTRACT:
Regimens for the therapeutic or prophylactic administration of pulmonary surfactant to infants exhibiting or at risk of developing bronchopulmonary dysplasia are disclosed.

REFERENCES:
patent: 4861756 (1989-08-01), Jackson
patent: 4918161 (1990-04-01), Steinbrink
patent: 5006343 (1991-04-01), Benson et al.
patent: 5024995 (1991-06-01), Robertson et al.
patent: 5164369 (1992-11-01), Cochrane et al.
patent: 5223481 (1993-06-01), Curstedt et al.
patent: 5238920 (1993-08-01), Sarin et al.
patent: 5260273 (1993-11-01), Cochrane et al.
patent: 5272252 (1993-12-01), McLean et al.
patent: 5302481 (1994-04-01), Ong
patent: 5407914 (1995-04-01), Cochrane et al.
patent: 5455227 (1995-10-01), Curstedt et al.
patent: 5753621 (1998-05-01), Dhaon et al.
patent: 5789381 (1998-08-01), Cochrane et al.
patent: 5827825 (1998-10-01), Takei et al.
patent: 5840527 (1998-11-01), Schilling, Jr. et al.
patent: 5863563 (1999-01-01), Scheele
patent: 5874406 (1999-02-01), Schafer et al.
patent: 5891844 (1999-04-01), Hafner
patent: 6013619 (2000-01-01), Cochrane et al.
patent: 6022955 (2000-02-01), Sarin et al.
patent: 6613734 (2003-09-01), Cochrane et al.
patent: 6660833 (2003-12-01), Walther et al.
patent: 2006/0078506 (2006-04-01), Niven et al.
patent: 86/03408 (1986-06-01), None
patent: 89/04326 (1989-05-01), None
patent: 97/19701 (1997-06-01), None
patent: 2002/062289 (2002-08-01), None
patent: 2005/115520 (2005-12-01), None
patent: 2006/026237 (2006-03-01), None
Hudak et al., A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome, Pediatrics, 1997, 100(1): 39-50.
Cochrane et al., The efficiency and safety of KL4-surfactant in preterm infants with respiratory distress syndrome, Am. J. Respir. Crit. Care Med.,1996, 153(1): 404-410.
Ngo et al., in The Protein Folding Problem and Tertiary Structure Prediction, 1994, Merz et al. (ed.), Birkhauser, Boston, MA, pp. 433 and 492-495.
Spear, M. Bronchopulmonary Dysplasia, Retrieved from the Internet <URL: www.kidshealth.org/parent/medical/lungs/bpd.html>.
Cochrane et al., Pulmonary surfactant protein B (SP-B): structure-function relationships, 1991, Science, vol. 254: 566-568.
Bancalari, E. et al., “Bronchopulmonary Dysplasia: Changes in Pathogenesis, Epidemiology and Definition,”Semin. Neonatol., vol. 8, pp. 63-71, 2003.
Cochrane, C.G. et al., “The Efficacy and Safety of KL4-Surfactant in Preterm Infants with Respiratory Distress Syndrome,” Am. J. Respir. Crit. Care Med., vol. 153(1), pp. 404-410, 1996.
Enhorning, G., “Pulsating Bubble Technique for Evaluating Pulmonary Surfactant,”J. Appl. Physiol., vol. 43, pp. 198-203, 1977.
Glasser, S.W. et al., “cDNA and Deduced Amino Acid Sequence of Human Pulmonary Surfactant-Associated Proteolipid SPL(Phe),”Proc. Natl. Acad. Sci., vol. 84(12), pp. 4007-4011, 1987.
Gortner, L. et al., “Early Treatment of Respiratory Distress Syndrome with Bovine Surfactant in Very Preterm Infants: A Multicenter Controlled Clinical Trial,”Pediatric Pulmonology, vol. 14(1), pp. 4-9, 1992.
Hopp, T.P. and Woods, K.R., “Prediction of Protein antigenic Determinants from Amino Acid Sequences,”Proc. Natl. Acad. Sci. USA, vol. 78(6), pp. 2824-3828, 1981.
Hudak, M.L. et al., “A Multicenter Randomized Masked Comparison Trial of Synthetic Surfactant Versus Calf Lung Surfactant Extract in the Prevention of Neonatal Respiratory Distress Syndrome,”Pediatrics, vol. 100(1), pp. 39-50, 1997.
Jobe, A.H. and Bancalari, E., “Bronchopulmonary Dysplasia,”Am. J. Respir. Crit. Care Med., vol. 163, pp. 1723-1729, 2001.
King, R.J. and Clements, J.A., “Surface Active Materials from Dog Lung. II. Composition and Physiological Correlations,”Am. J. Physiol., vol. 223, pp. 715-726, 1972.
Merrifield, R.B., “Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide,” J.Am. Chem.. Soc., vol. 85, pp. 2149-2154, 1962.
Morley, C. and Davis, P., “Surfactant Treatment for Premature Lung Disorders: A Review of Best Practices in 2002,”Ped. Resp. Rev., vol. 5(Suppl. A), pp. S299-S304, 2004.
Ngo, J.T. et al., Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox,in The Protein Folding Problem and Teritiary Structure Prediction, 1994, Merz et al. (ed)., Birkhauser, Boston, MA, pp. 433 and 492-495.
Revak, S.D. et al., “Efficacy of Synthetic Peptide-Containing Surfactant in the Treatment of Respiratory Distress Syndrome in Preterm Infant Rhesus Monkeys,”Am. Rev. Respir. Dis., vol. 134, pp. 1258-1265, 1986.
Revak, S.D. et al., “Reconstitution of Surfactant Activity Using Purified Human Apoprotein and Phospholipids Measured In Vitro and In Vivo,”Am. Rev. Respir. Dis., vol. 134(6), pp. 1258-1265, 1986.
Robertson, B., “Surfactant Substitution; Experimental Models and Clinical Applications,”Lung, vol. 158, pp. 57-68, 1980.
Stewart, J.M. and Young, J.D., “Laboratory Techniques in Solid Phase Peptide Synthesis,”Solid Phase Peptides Synthesis, Chap. 2, W.H. Freeman & Co., pp. 27-62, 1969.
Zalipsky, S., “Chemistry of Polyethylene Glycol Conjugates with Biologically Active Molecules,”Adv. Drug. Del. Rev., vol. 16, pp. 157-182, 1995.
Zhao, X. and Harris, J.M., “Novel Degradable Poly(ethylene glycol) Esters for Drug Delivery,”A.C.S. Symposium Series, vol. 680, pp. 458-472, 1997.
Ballard, P., et al., “Surfactant Protein Profile of Pulmonary Surfactant in Premature Infants”,American Journal Of Respiratory And Critical Care Medicine, vol. 168, pp. 1124-1128, 2003.
Bissinger, R. et al., “Secondary Surfactant Deficiency in Neonates”,Journal of Perinatology., vol. 24, pp. 663-666, 2004.
Cochrane, C., et al., “The Efficacy and Safety of KL4-Surfactant in Preterm Infants with Respiratory Distress Syndrome”,American Journal Of Respiratory And Critical Care Medicine, vol. 153, pp. 404-410, 1996.
Cogo, P., et al., “Surfactant Kinetics in Preterm Infants on Mechanical Ventilation Who Did Not Develop Bronchopulmonary Dysplasia”,Pediatric Critical Care, vol. 31, No. 5, pp. 1532-1538, 2003.
Davis, J., et al., “High-Frequency Jet Ventilation and Surfactant Treatment of Newborns With Severe Respiratory Failure”,Pediactric Pulmonology, vol. 13, pp. 108-112, 1992.
Hoekstra, R., et al., “Improved Neonatal Survival Following Multiple Doses of Bovine Surfactant in Very Premature Neonates at Risk for Respiratory Distress Syndrome”,Pediatrics, vol. 88, No. 1, pp. 10-18, 1991.
McMillan, D., et al., “Effects of Two Rescue Doses of Synthetic Surfactant in 344 Infants with Respiratory Distress Syndrome Weighing 750 to 1249 Grams: A Double-blind, Placebo-Controlled Multicenter”,The Journal of Pediatrics, vol. 126, No. 5, Part 2, pp. 90-102, 1995.
Merrill, J., et al., “Dysfunction of Pulmonary Surfactant in Chronically Ventilated Premature Infants”,Pediactric Research, vol. 56, No. 6, pp. 108-112, 1992.
Pandit, P., et al., “Surfactant Replacement in Neonates With Early Chronic Lung Disease”,Pediatrics, vol. 95, pp. 851-854, 1995.
Smyth, J., et al., “Double-blind, Randomized, Placebo-Controlled Canadian Multicenter Trial of Two Doses of Synthetic Surfactant or Air Placebo in 224 Infants Weighting 500 to 749 Grams with Respiratory Distress Syndrome”,The Journal of Pediatrics, vol. 126, No. 5, Part 2, pp. S81-S89, 1995.
Soll, R., et al., “Multicenter Trial of Single-Dose Modified Bovine Surfactant Extract (Survanta) for Prevention of Respiratory Distress Syndrome”, Pediatrics, vol. 85, No. 6, 1990.

Affiliated with

Also associated with

Rating

Surfactant treatment regimen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Surfactant treatment regimen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Surfactant treatment regimen will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4147597